oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer
Departments of Cardiothoracic Surgery, Örebro University Hospital, Örebro, Sweden.
Departments of Cardiothoracic Surgery, Örebro University Hospital, Örebro, Sweden.
Department of Pulmonary Medicine, Örebro University Hospital, Örebro, Sweden.
Department of Transfusion Medicine, Örebro University Hospital, Örebro, Sweden.
Show others and affiliations
2003 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 42, no 4, p. 338-341Article in journal (Refereed) Published
Abstract [en]

The survival and outcome rates of 284 patients who underwent surgical treatment for non-small cell lung cancer were assessed retrospectively. Resectability rate was 94.1%, hospital mortality 3.9% (n = 11) and the mortality rates in patients who underwent pneumonectomy or lobectomy were 8.9% and 0.6%, respectively. The overall 5-year survival was 43.6%. Female gender, earlier stages of disease and a complete resection were strongly predictive for a long-term survival. Women in stage IA disease had a 5-year survival rate of 92.7%. The 5-year survival rate for patients in stages IIIA and N2 disease who underwent a complete resection was 21.9%, and 9% for those who did not undergo a complete resection. It is concluded that the best surgical results were observed in women who were operated on at an early stage of disease. A complete resection also contributed to a better outcome, even for patients in stage IIIA and N2 disease.

Place, publisher, year, edition, pages
Oslo, Norway: Taylor & Francis, 2003. Vol. 42, no 4, p. 338-341
National Category
Cancer and Oncology Clinical Laboratory Medicine
Identifiers
URN: urn:nbn:se:oru:diva-49509DOI: 10.1080/02841860310003536ISI: 000184142200011PubMedID: 12899506Scopus ID: 2-s2.0-0037488305OAI: oai:DiVA.org:oru-49509DiVA, id: diva2:914902
Available from: 2016-03-27 Created: 2016-03-25 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Karlsson, Mats G

Search in DiVA

By author/editor
Karlsson, Mats G
In the same journal
Acta Oncologica
Cancer and OncologyClinical Laboratory Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 294 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf